AXHLF - EVITRADE Health Systems Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.4411
-0.0178 (-3.88%)
As of 9:31AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.4589
Open0.4428
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.4411 - 0.4505
52 Week Range0.1550 - 1.8940
Volume2,439
Avg. Volume1,142
Market Cap16.161M
Beta0.96
PE Ratio (TTM)N/A
EPS (TTM)-0.9330
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire5 hours ago

    Trump’s Backing Anti-Cannabis Laws Set to Go Up in Smoke - Aiding Evitrade’s Nutraceutical Efforts

    EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: AXHLF) (the “Company” or “Evitrade”) is a Canadian company but has taken a keen interest of late in American legislative politics. President Donald Trump has indicated he will “probably” back the bill, greatly increasing its odds of passage. Not because it legalizes cannabis throughout the United States – it doesn’t.

  • GlobeNewswire5 days ago

    EVITRADE Health Systems Signs Definitive Agreement to Bring Best of Breed Science to the Cannabis Industry

    EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: AXHLF) (the “Company”) announces that it has signed the Definitive Agreement with Cantech Molecular Research Inc. (“Cantech”). Among the many progressive capabilities EVA will gain with the Cantech acquisition is the ability to produce true homozygotic plants with a highly select and consistent set of traits.

  • FSCWire5 days ago

    EVITRADE Health Systems Signs Definitive Agreement to Bring Best of Breed Science to the Cannabis Industry

    EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: AXHLF) (the “Company”) announces that it has signed the Definitive Agreement with Cantech Molecular Research Inc. (“Cantech”). Among the many progressive capabilities EVA will gain with the Cantech acquisition is the ability to produce true homozygotic plants with a highly select and consistent set of traits.

  • GlobeNewswire6 days ago

    Canadian Cannabis Stocks “Naturally” Changing the World; New Approaches to Anxiety and Sleep Disorders, Pain Treatment, Drug Delivery and Food Supplements

    Investorideas.com, a global news source and investor resource covering cannabis stocks issues a sector news alert on Canadian cannabis stocks introducing natural and organic alternatives to key health issues using cannabinoids.  A global revolution is taking place in healthcare, life sciences and the food and beverage industry with applications including treatment of anxiety and sleep disorders, pain management, drug delivery and food supplements. The global landscape is changing so rapidly that in some instances, cannabis is now taking on traditional healthcare at par. Troy Dayton, CEO and Founder of the Arcview Group, told Investor Ideas at the recently held Arcview Investor Forum in Vancouver B.C., “What’s happening in Germany is very interesting.

  • GlobeNewswire8 days ago

    EVITRADE Health Systems to Bring Blockchain Security to the Hemp Industry

    EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: AXHLF) (the “Company”) announces that it has embarked on a program to utilize its contacts in the blockchain technology space to marry the security of blockchain technology with the Company’s interest in the international industrial Hemp trade. The Company has signed a Letter of Intent with Veri-Medical Systems (“VeriMed” or the “Company”) to potentially acquire the Company which is involved in developing a blockchain based “seed-to-sale” protocol focussed on enhancing the integrity of the sale of Hemp based products such as cannabidiol (“CBD”).  “We are very excited to be standing at the cross-road of being able to combine the security that block-chain technologies offer with the bright future of Hemp based protocols and products” said C.K., CEO for Evitrade Health.

  • FSCWire8 days ago

    EVITRADE Health Systems to Bring Blockchain Security to the Hemp Industry

    EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: AXHLF) (the “Company”) announces that it has embarked on a program to utilize its contacts in the blockchain technology space to marry the security of blockchain technology with the Company’s interest in the international industrial Hemp trade. The Company has signed a Letter of Intent with Veri-Medical Systems (“VeriMed” or the “Company”) to potentially acquire the Company which is involved in developing a blockchain based “seed-to-sale” protocol focussed on enhancing the integrity of the sale of Hemp based products such as cannabidiol (“CBD”).  “We are very excited to be standing at the cross-road of being able to combine the security that block-chain technologies offer with the bright future of Hemp based protocols and products” said C.K., CEO for Evitrade Health.